MARKET

ARKG

ARKG

ARK Genomic Revolution ETF
BATS
28.76
+0.21
+0.74%
After Hours: 28.84 +0.08 +0.28% 19:54 03/28 EDT
OPEN
28.76
PREV CLOSE
28.55
HIGH
29.11
LOW
28.48
VOLUME
2.30M
TURNOVER
0
52 WEEK HIGH
38.97
52 WEEK LOW
21.97
TOTAL ASSET
1.59B
YTD YIELD
2.70%
1D
5D
1M
3M
1Y
5Y
Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares
Cathie Wood’s Ark Invest increased its stake in Moderna Inc. (NASDAQ:MRNA) on Tuesday. The biotech firm is a leading COVID-19 vaccine maker. The company has a series of upcoming catalysts for the biotech firm. Over 12 months Moderna stock has declined 26.89%, but the stock has gained 8%.
Benzinga · 2d ago
Cathie Wood's Ark Takes Profits In Rallying Crypto Stocks, Trims Nvidia And This COVID-19 Play Further
Cathie Wood’s Ark Investment Management sold shares of three high-profile stocks linked to the cryptocurrency space on Monday. The three stocks, all with links to the space, rallied on the rebound in cryptocurrency prices. Ark sold shares in cryptocurrency exchange Coinbase Global, Inc., trading platform Robinhood Markets, and Jack Dorsey's payment processing firm Block.
Benzinga · 2d ago
Weekly Report: what happened at ARKG last week (0318-0322)?
Weekly Report · 3d ago
ARKG: Massive Potential, But Not Worth The Risk Yet For These 3 Reasons
ARK Genomic Revolution ETF warrants a hold rating due to underdeveloped technology, legal hurdles, and unresolved ethical dilemmas. The fund's performance has significantly underperformed the S&P 500 Index. ARKG has a relatively high expense ratio with no dividend yield and is concentrated in the healthcare sector.
Seeking Alpha · 3d ago
GNOM: Genomics Still Waiting For Its 'ChatGPT' Moment
Global X Genomics & Biotechnology ETF invests across companies benefiting from advancements in the field of genomics within biotechnology. The fund's historical performance has been poor amid volatile stock prices for underlying holdings. Genomics may be the future, but still missing a blockbuster application to drive momentum in the segment.
Seeking Alpha · 6d ago
Taking Stock: Q2 2024 Equity Market Outlook
Seeking Alpha · 6d ago
Is Cathie Wood Buying The Rumor? Ark More Than Doubles Stake In This COVID-19 Vaccine Maker Ahead Of Flurry Of Catalysts
Cathie Wood’s Ark Invest has been buying up shares of Moderna, Inc. In March. The firm has more than doubled its stake in the biotech company since the fourth quarter. Moderna is now the 19th biggest holding of Ark Invest's flagship biotech fund.
Benzinga · 03/21 10:00
Wednesday's ETF Movers: ILF, ARKG
NASDAQ · 03/20 16:35
More
Profile
Fund Name
ARK Genomic Revolution ETF
Inception Date
2014-10-31
Benchmark
NASDAQ Health Care GR EUR
Advisor Company
ARK Investment Management LLC
Custodian
Bank of New York Mellon
Manager
Catherine Wood